At Genentech, we apply the same science-based approach to environmental sustainability as we do to creating medicines for people with serious illnesses. As a healthcare company, it’s especially important for us to model the change required to improve the health of every person on the planet.
That’s why we have set ambitious sustainability goals to reduce our global environmental footprint by 50% by 2030 and to eliminate our Scope 1 and 2 emissions by 2050. In support of these goals, we are committed to achieving
We track environmental impacts across all Genentech sites and we report our company-wide data and performance trends in our Sustainability Data and Trends Report. As we drive towards our 2030 goal to halve our environmental footprint, we are working towards interim 2025 milestones that will guide our progress for the South San Francisco campus.